Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies.

Yu, Li-Li; He, Zhi-Lin; Qian, Xin-Lai

Yu, Li-Li; He, Zhi-Lin; Qian, Xin-Lai.

Afiliação

Yu LL; Department of Pathology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang Medical University, Xinxiang 453003, Henan Province, China.
He ZL; Department of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, Henan Province, China. merrys222@126.com.
Qian XL; Department of Pathology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang Medical University, Xinxiang 453003, Henan Province, China.

World J Gastroenterol ; 30(24): 3120-3122, 2024 Jun 28.

Article em En | MEDLINE | ID: mdl-38983961

ABSTRACT

ABSTRACT

Immune checkpoint inhibitors (ICIs) are widely used due to their effectiveness in treating various tumors. Immune-related adverse events (irAEs) are defined as adverse effects resulting from ICI treatment. Gastrointestinal irAEs are a common type of irAEs characterized by intestinal side effects, such as diarrhea and colitis, which may lead to the discontinuation of ICIs.

Assuntos

Gastrite; Inibidores de Checkpoint Imunológico; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Gastrite/induzido quimicamente; Gastrite/imunologia; Gastrite/diagnóstico; Gastrite/tratamento farmacológico; Neoplasias/tratamento farmacológico; Neoplasias/imunologia

Palavras-chave

Autoimmune responses; Immune checkpoint inhibitor; Immune checkpoint inhibitor-related gastritis; Immune-related adverse events; Immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Gastrite / Inibidores de Checkpoint Imunológico Limite: Humans Idioma: En Revista: World J Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google